Will the WSJ do an expose-style piece on Bryan Johnson before 2027?
One-OffSamenleving en cultuur2mndManifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige gemeenschapsvoorspellingJa 60.9%
Voorspellers
6
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 11 uur geleden
Verouderd11 feb 24, 22:28 UTC1 jan 27, 20:59 UTC
Trends
Gerelateerde Markten
Gerelateerde vragen voor context, geen vergelijking van gelijkwaardige contracten.
Will Bryan Johnson dunk before 2027?
PolymarketWill Bryan Johnson propose to his co-founder before 2027?
PolymarketWill Bryan Johnson dunk in 2026?
Manifold MarketsWill Bryan Johnson inject minicircles/plasmids of the yamanaka factors into his body by 2026?
Manifold MarketsWill Jose Luis Ricon have more microplastics in his 2026 semen/ejaculate than Bryan Johnson in his 2026 semen/ejaculate?
Manifold MarketsWill Bryan Johnson [BJ!] get a well-deserved BJ in 2025 or 2026?
Manifold MarketsRegels
This market will resolve as YES if The Wall Street Journal (WSJ) or WSJ Magazine publishes a feature-length article that aims to critically examine or reveal previously undisclosed aspects of Bryan Johnson or his "Blueprint/Don't Die" brand.
- The article must:
- Be explicitly investigative or exposé in nature, providing a critical analysis or uncovering behind-the-scenes details.
- Contain a predominantly negative tone, questioning or criticizing the practices, ethics, or impact of Bryan Johnson and/or the "Blueprint" brand.
- Be published between the market's start date and its closing date.
- For clarity, a "feature-length" article is defined as one that goes beyond mere reporting to offer in-depth analysis, commentary, or investigative content, typically exceeding 1,000 words. e.g https://www.wsj.com/style/dave-rachel-hollis-disney-1ffac082 or https://www.wsj.com/articles/theranos-has-struggled-with-blood-tests-1444881901
